Peripheral vaccination-induced brain-resident memory CD8+ T cells durably protect mice against intracranial malignancy
Open Access
- 15 April 2026
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 136 (8)
Abstract
Primary and metastatic brain tumors exhibit resistance to immunotherapies that demonstrate efficacy in peripheral cancer settings. While many immunotherapies aim to enhance CD8 + T cell infiltration and functionality in established tumors, identification of neoantigens support emerging immunopreventative tactics against brain cancer. Functionally potent tissue-resident memory CD8 + T cells (T RM ) can be generated in the brain following peripheral infection or vaccination. However, the ability of brain T RM to prevent intracranial malignancy remains unknown. Here, mice were seeded with tumor-specific or bystander brain T RM via peripheral infection prior to depletion of circulating memory T cells (T CIRCM ) and subsequent brain tumor challenge. Tumor-specific brain T RM durably protected mice against intracranial malignancy even in the absence T CIRCM . These brain T RM persisted in tumor-surviving mice and protected against a second antigen-matched challenge. Importantly, a translationally-relevant mRNA-lipid nanoparticle (LNP) vaccine phenocopied peripheral infection-induced outcomes, generating functional brain T RM that controlled tumor growth. Altogether, this work points to the utility of brain T RM in cancer immunoprevention, supporting the development of antitumor mRNA-LNP vaccines to bolster brain immunity.Keywords
Funding Information
- National Institutes of Health (AI167847,AI178159,AI114543,GM134880,NS122174,NS103212,AI125446,AI127481,167058,T32AI007260,T32CA078586,F32AI174382,T32GM139776)
- HHMI Hanna H. Gray Fellow Program (01)
- National Institutes of Health (K99AI190129-)
This publication has 90 references indexed in Scilit:
- Brain resident memory T cells rapidly expand and initiate neuroinflammatory responses following CNS viral infectionBrain, Behavior, and Immunity, 2023
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent GlioblastomaJAMA Oncology, 2022
- Identification of tumor antigens and immune subtypes of glioma for mRNA vaccine developmentCancer Medicine, 2022
- Functional virus-specific memory T cells survey glioblastomaCancer Immunology, Immunotherapy, 2022
- Are 90% of deaths from cancer caused by metastases?Cancer Medicine, 2019
- Methotrexate Chemotherapy Induces Persistent Tri-glial Dysregulation that Underlies Chemotherapy-Related Cognitive ImpairmentCell, 2019
- SOX2 immunity and tissue resident memory in children and young adults with gliomaJournal of Neuro-Oncology, 2017
- Emerging Biological Principles of MetastasisCell, 2017
- Epidemiology of Brain MetastasesCurrent Oncology Reports, 2011
- Predilection of brain metastasis in gray and white matter junction and vascular border zonesCancer, 1996